ZielBio

About

ZielBio is an early-stage biotechnology company that identifies novel high value disease targets and develops therapeutic interventions to improve patient outcomes. Our proprietary drug discovery platform Zielfind™ combines the power of functional, high throughput screening with large content data analytics to identify high value targets. We have a promising pipeline of therapies and targets, including lead compound ZB131, a proprietary humanized monoclonal antibody against cell surface plectin (CSP) a cancer target identified through Zielfind™.

Contact

Anne Heldreth

Phone Number

(434) 202-7771

Sector

Therapeutics

Company Stage

Startup

Funding Sources

  • Private Investment
  • Venture Capital

Address

705d Dale Avenue
Charlottesville, VA 22903